Results 51 to 60 of about 5,625 (178)

Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium

International Journal of COPD, 2010
Donald P TashkinDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA,Los Angeles, CA, USAAbstract: The course of COPD is punctuated by acute exacerbations that are associated with an increase ...
Donald P Tashkin
doaj  

Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A Prospective Pilot Study

Pharmaceutics, 2020
The effects of tiotropium bromide soft mist inhalers (SMIs) in patients with chronic obstructive pulmonary disease (COPD) receiving mechanical ventilation remain unexplored.
Pin-Kuei Fu, Yu-Feng Wei, Chau-Chyun Sheu, Chen-Yu Wang, Chi-Kuei Hsu, Chia-Min Chen, Wei-Chih Chen, Kuang-Yao Yang   +7 more
doaj   +1 more source

A Case of Malignant Hyperthermia Following Intubation With Rocuronium

Case Reports in Critical Care, Volume 2026, Issue 1, 2026.
Background Malignant hyperthermia (MH) is an inherited autosomal‐dominant disorder of ryanodine receptors. While typically associated with exposure to inhaled anesthetics or depolarizing neuromuscular blocking agents (NMBAs), there have been reported cases following exposure to other conditions and medications including nondepolarizing neuromuscular ...
Kristin Woodring, Nicholas Liotta, Dominick Roto, Christine M. Groth, Naohiro Komura   +4 more
wiley   +1 more source

Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studies

International Journal of COPD, 2014
Richard ZuWallack,1 Lisa Allen,2 Gemzel Hernandez,2 Naitee Ting,2 Roger Abrahams3 1Saint Francis Hospital and Medical Center, Hartford, CT, USA; 2Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA; 3Morgantown Pulmonary Associates, Morgantown,
ZuWallack R, Allen L, Hernandez G, Ting N, Abrahams R   +4 more
doaj  

Abstract Supplement

Pulmonary Medicine, Volume 2026, Issue 1, 2026.
 
Marzia Folegani, Semonti Nandi
wiley   +1 more source

Rational Design of Hyoscyamine 6β‐Hydroxylase for the Efficient Production of Scopolamine

Plant Biotechnology Journal, Volume 24, Issue 5, Page 3368-3370, May 2026.
Yong Meng, Yicheng Wang, Wentang Chen, Junnan Li, Siyuan Liao, Chunxian Yang, Lingjiang Zeng, Xiaozhong Lan, Min Chen, Zhihua Liao, Junlan Zeng   +10 more
wiley   +1 more source

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

International Journal of COPD, 2015
David MG Halpin,1 Ronald Dahl,2 Christoph Hallmann,3 Achim Mueller,3 Donald Tashkin4 1NHS SW, Royal Devon and Exeter Hospital, Exeter, Devon, England, UK; 2Allergy Centre, Odense University Hospital, Odense, Denmark; 3Boehringer Ingelheim Pharma GmbH ...
Halpin DMG, Dahl R, Hallmann C, Mueller A, Tashkin D   +4 more
doaj  

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium

Respiratory Research, 2012
Randomised, double-blind, controlled trials are considered the gold standard for evaluating a pharmacological agent, as they minimise any potential bias.
Beeh Kai-Michael, Beier Jutta, Donohue James F   +2 more
doaj   +1 more source

Ten years of tiotropium: clinical impact and patient perspectives

International Journal of COPD, 2013
Abebaw M Yohannes,1 Martin J Connolly,2 Nicola A Hanania31Manchester Metropolitan University, Department of Health Professions, Manchester, UK; 2University of Auckland, Freemasons’ Department of Geriatric Medicine, Auckland, New Zealand ...
Yohannes AM, Connolly MJ, Hanania NA
doaj  

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions

BMC Pulmonary Medicine, 2010
Background Tiotropium is reimbursed since March 2004 in Belgium for the treatment of Chronic Obstructive Pulmonary Disease (COPD). Questions however remain on this product's value for money.
Thiry Nancy, Devriese Stephan, Neyt Mattias, Van den Bruel Ann   +3 more
doaj   +1 more source